Developer docs
API playgroundTry for free, no card

Search company profiles

CGD Society

Full company profile

uuid0044ary

Namestring
CGD Society
Legal namestring
Chronic Granulomatous Disorder Society
Websiteurl
cgdsociety.org
Company typeenum
Private
Founded yearstring
-
Descriptiontext

CGD Society is a UK-registered charity (registered charity number 1143049, company number 07607593), founded in 1991 and headquartered in Epsom with a postal address in Dartford, that provides support, information, and advocacy for individuals and families affected by Chronic Granulomatous Disorder (CGD), a rare primary immunodeficiency affecting an estimated 4-6 people per million. The organization funds a UK-based Clinical Nurse Specialist, runs a telephone and email helpline (0800 987 8988), operates a Family Support Fund and pre-payment prescription assistance, and provides bereavement and mental health support. It also curates patient-facing resources, hosts a Medical Advisory Panel, and maintains a research portfolio that includes clinical-trial information and patient advisory panels for gene therapy developers such as Ensoma and Prime Medicine.

The charity's revenue model is donation-led: it depends on regular giving, one-time donations, corporate partnerships, an annual membership programme, branded merchandise sales via a WooCommerce webshop, and the Jeans for Genes Day fundraising campaign. Core services are provided free of charge to beneficiaries; there is no service-pricing model. Its operating technology is a standard nonprofit stack (WordPress content management, WooCommerce webshop, Google Analytics, Mailchimp newsletters) with social media presence on LinkedIn, Instagram, X, and Facebook.

CGD Society serves approximately 1,500 members worldwide, including diagnosed individuals, families, X-linked CGD carrier females, and (for clinical resources) medical professionals. It operates with a 9-employee base and is governed by a board of trustees; Josh Stevens assumed the chair role in 2024. The charity is part of the Gene People Partnership Network and receives support from the National Lottery Community Fund, with strategic research collaborations including UCL Institute of Immunity and Transplantation and Great Ormond Street Hospital on gene therapy and stem cell transplantation studies.

Short descriptiontext

CGD Society is a UK-registered charity founded in 1991 that provides support, information, and advocacy for individuals and families affected by Chronic Granulomatous Disorder, a rare primary immunodeficiency. It funds a Clinical Nurse Specialist, runs a helpline, Family Support Fund, and research engagement with gene therapy developers.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersEpsom, United Kingdom
HQ citystring
Epsom
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
rare disease support, patient advocacy, genetic disorder charity, family support services, health charity
Industry2 codes
PRIMARYBPAGACAM
Rare Disease & Special Needs Support Organizations
SECONDARYEDAJAIAK
Family & Community Support Services (Case Management, Referrals)
Education/K–12 / Primary & Secondary Education/K–12 Student Health, Safety & Wellbeing Services (Counseling, Mental Health, SEL, Safeguarding)
NAICS code4 codes
  • Other Individual and Family Services624190
  • Individual and Family Services6241
  • Child and Youth Services62411
  • Social Assistance624
SIC code2 codes
  • Services-Social Services8300
  • Services-Misc Health & Allied Services, Nec8090
Product category
Patient Advocacy / Rare Disease Charity
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model5 records
1Donations and Regular Giving
TypeGrants Donations
Description

The CGD Society relies on regular donations from supporters to provide ongoing support services to individuals and families affected by CGD. They have a regular giving program and one-time donation options.

cgdsociety.org
2Jeans for Genes Campaign
TypeGrants Donations
Description

Annual fundraising campaign that raises awareness and funds for genetic conditions in the UK.

cgdsociety.org
3Corporate Support
TypeGrants Donations
Description

Partnerships with corporate entities for fundraising and support.

cgdsociety.org
4Membership
TypeSubscription Recurring
Description

Annual membership program providing access to newsletters and community support.

cgdsociety.org
5Merchandise Sales
TypeOne Time License
Description

Webshop sales of branded merchandise through WooCommerce platform.

cgdsociety.org
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure
GTM typeB2C
B2C
Offering typeServices
Services
Brand1 record
1Jeans for Genes Day
Description

Campaign that raises awareness of all genetic health conditions in the UK and raises money to fund projects for those affected by genetic conditions

cgdsociety.org
Core offering1 text field

The CGD Society is a UK-registered charity providing support, information, and advocacy for individuals and families affected by Chronic Granulomatous Disorder (CGD), a rare primary immunodeficiency. Its offerings include a telephone and email helpline, UK-based clinical nurse specialist services, a Family Support Fund, mental health and bereavement support, educational resources, and funding for research and clinical trials.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • 17 pre-payment prescriptions provided to families in 2024-2025
+3 more records
Product overview1 text field

CGD Society is a charitable organization providing support, information, and advocacy for individuals and families affected by Chronic Granulomatous Disorder. The organization offers a unified service portfolio centered on patient and family support, including a helpline, UK-based nursing services, family support fund, bereavement support, mental health support, and educational resources. Additional services include a research portfolio funding clinical trials and medical professional resources. The charity also operates a Jeans for Genes fundraising campaign and provides membership programs with newsletters. CGD Society does not offer a technology product platform but provides charitable services focused on support, awareness, and research funding for this rare genetic condition.

Product and service8 records
1Support Services
CategoryPatient support services
2Information Resources
CategoryEducational resources
3Research Portfolio
CategoryResearch funding and coordination
4Medical Professional Resources
CategoryClinical resources for healthcare professionals
5Family Support Fund
CategoryFinancial support services
6Jeans for Genes Campaign
CategoryFundraising campaign
7Membership Program
CategoryMembership program
8Pre-payment Prescription Service
CategoryMedication financial assistance
Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership5 partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

CGD Society partnered with Ensoma, a genomic medicines company, to support the development of gene therapy for X-linked chronic granulomatous disease (X-CGD). The charity organized a patient advisory panel of five individuals directly affected by CGD to provide balanced feedback on the ongoing clinical trial. This collaboration ensures patient voices are integrated into the clinical development process.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Prime Medicine developed PM359 prime editing programme for p47phox CGD. CGD Society maintained engagement with the company and shared community letters regarding their decision to deprioritize the CGD programme. The charity continues to monitor developments and explore partnership opportunities for PM359 continuation.

3UCL Institute of Immunity and Transplantation
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Collaboration with UCL on research comparing allogeneic stem cell transplantation outcomes in adults with primary immunodeficiencies including CGD. The study found that transplant outcomes were better when performed at expert centres like UCLH or Newcastle.

cgdsociety.org
Strategic tierCoreTypeStrategic or Co-development Partner
Description

GOSH conducted pioneering gene therapy treatment on Remi, the first person in the world with p47 CGD to receive this therapy. The CGD Society celebrates this breakthrough and works with GOSH to raise awareness of treatment advances.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

The CGD Society is part of the Gene People Partnership Network, a coalition of genetic condition charities working together for greater impact.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

US-based umbrella organization for rare diseases. Comparable in providing advocacy, research funding programs, and patient resource infrastructure across the rare disease space that includes CGD.

2British Society for Immunology
TypeRegional player
Description

UK professional body for immunologists. Comparable as an ecosystem participant that engages medical professionals treating primary immunodeficiencies, though it serves clinicians rather than patients directly.

3Metabolic Support UK (formerly CLIMB)
TypeDirect peer
Description

UK charity supporting patients and families affected by inherited metabolic diseases. Closely comparable operating model: small team, helpline, family support, information resources, and research engagement for a rare genetic condition.

TypeBroad incumbent
Description

UK national alliance of over 200 patient organizations supporting people with genetic conditions. Comparable as a broader policy/advocacy incumbent that operates across the same genetic-disease ecosystem.

TypeEmerging player
Description

UK charity supporting families with disabled children, including those with rare genetic conditions. Comparable in providing family support, helpline, and information services to a partially overlapping beneficiary population.

6PID UK
TypeDirect peer
Description

UK-based primary immunodeficiency patient organization. Closest UK peer offering helpline, family support, and medical-professional resources across the same PID disease area that includes CGD.

TypeDirect peer
Description

US-based patient organization for primary immunodeficiencies (PIDs), including CGD. Directly comparable mission: provides patient/family support, physician education, advocacy, and research funding for the same rare immunodeficiency community.

TypeDirect peer
Description

Global foundation dedicated to primary immunodeficiencies including CGD. Comparable as a charity funding research, physician education, and patient advocacy for the same disease class.

TypeBroad incumbent
Description

UK umbrella alliance of genetic condition charities of which CGD Society is a member. Broad incumbent that aggregates policy, awareness, and network services across many rare genetic conditions, including CGD.

TypeBroad incumbent
Description

National alliance for the rare disease community in the UK. Comparable in advocacy mission and stakeholder convening role across rare conditions including CGD, though not condition-specific.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

Integration9 records

Each record includes

Title, Type, Description, Source

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

CGD Society

Patient Advocacy / Rare Disease Charitycgdsociety.org

CGD Society is a UK-registered charity founded in 1991 that provides support, information, and advocacy for individuals and families affected by Chronic Granulomatous Disorder, a rare primary immunodeficiency. It funds a Clinical Nurse Specialist, runs a helpline, Family Support Fund, and research engagement with gene therapy developers.

What CGD Society does

CGD Society is a UK-registered charity (registered charity number 1143049, company number 07607593), founded in 1991 and headquartered in Epsom with a postal address in Dartford, that provides support, information, and advocacy for individuals and families affected by Chronic Granulomatous Disorder (CGD), a rare primary immunodeficiency affecting an estimated 4-6 people per million. The organization funds a UK-based Clinical Nurse Specialist, runs a telephone and email helpline (0800 987 8988), operates a Family Support Fund and pre-payment prescription assistance, and provides bereavement and mental health support. It also curates patient-facing resources, hosts a Medical Advisory Panel, and maintains a research portfolio that includes clinical-trial information and patient advisory panels for gene therapy developers such as Ensoma and Prime Medicine.

The charity's revenue model is donation-led: it depends on regular giving, one-time donations, corporate partnerships, an annual membership programme, branded merchandise sales via a WooCommerce webshop, and the Jeans for Genes Day fundraising campaign. Core services are provided free of charge to beneficiaries; there is no service-pricing model. Its operating technology is a standard nonprofit stack (WordPress content management, WooCommerce webshop, Google Analytics, Mailchimp newsletters) with social media presence on LinkedIn, Instagram, X, and Facebook.

CGD Society serves approximately 1,500 members worldwide, including diagnosed individuals, families, X-linked CGD carrier females, and (for clinical resources) medical professionals. It operates with a 9-employee base and is governed by a board of trustees; Josh Stevens assumed the chair role in 2024. The charity is part of the Gene People Partnership Network and receives support from the National Lottery Community Fund, with strategic research collaborations including UCL Institute of Immunity and Transplantation and Great Ormond Street Hospital on gene therapy and stem cell transplantation studies.

CGD Society firmographics

Firmographics
Name
CGD Society
Legal name
Chronic Granulomatous Disorder Society
Website
https://cgdsociety.org
Company type
Private
Operating status
Operating
Headcount range
1–10 employees
Short description
CGD Society is a UK-registered charity founded in 1991 that provides support, information, and advocacy for individuals and families affected by Chronic Granulomatous Disorder, a rare primary immunodeficiency. It funds a Clinical Nurse Specialist, runs a helpline, Family Support Fund, and research engagement with gene therapy developers.
Ownership category
akta.pro rank

CGD Society industry classification

Industry
Product category
Patient Advocacy / Rare Disease Charity
NAICS
Other Individual and Family Services (624190), Individual and Family Services (6241), Child and Youth Services (62411), Social Assistance (624)
SIC
Services-Social Services (8300), Services-Misc Health & Allied Services, Nec (8090)
akta.pro industry
PRIMARYBPAGACAM
Rare Disease & Special Needs Support Organizations
SECONDARYEDAJAIAK
Family & Community Support Services (Case Management, Referrals)
Education/K–12 / Primary & Secondary Education/K–12 Student Health, Safety & Wellbeing Services (Counseling, Mental Health, SEL, Safeguarding)

Keywords

  • Rare disease support
  • Patient advocacy
  • Genetic disorder charity
  • Family support services
  • Health charity

Where CGD Society is headquartered

Location

Headquarters

HQ city
Epsom
HQ country
United Kingdom
HQ region
Europe

Offices2 records

Markets served

CGD Society business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

  1. Donations and Regular Giving: The CGD Society relies on regular donations from supporters to provide ongoing support services to individuals and families affected by CGD. They have a regular giving program and one-time donation options.
  2. Jeans for Genes Campaign: Annual fundraising campaign that raises awareness and funds for genetic conditions in the UK.
  3. Corporate Support: Partnerships with corporate entities for fundraising and support.
  4. Membership: Annual membership program providing access to newsletters and community support.
  5. Merchandise Sales: Webshop sales of branded merchandise through WooCommerce platform.

Go-to-market motion2 records

Distribution channels4 records

Marketing channels5 records

CGD Society product offering

Product offering

Core offering

The CGD Society is a UK-registered charity providing support, information, and advocacy for individuals and families affected by Chronic Granulomatous Disorder (CGD), a rare primary immunodeficiency. Its offerings include a telephone and email helpline, UK-based clinical nurse specialist services, a Family Support Fund, mental health and bereavement support, educational resources, and funding for research and clinical trials.

Product overview

CGD Society is a charitable organization providing support, information, and advocacy for individuals and families affected by Chronic Granulomatous Disorder. The organization offers a unified service portfolio centered on patient and family support, including a helpline, UK-based nursing services, family support fund, bereavement support, mental health support, and educational resources. Additional services include a research portfolio funding clinical trials and medical professional resources. The charity also operates a Jeans for Genes fundraising campaign and provides membership programs with newsletters. CGD Society does not offer a technology product platform but provides charitable services focused on support, awareness, and research funding for this rare genetic condition.

Differentiator

Problem solved

Functional benefit

Brands

  • Jeans for Genes Day: Campaign that raises awareness of all genetic health conditions in the UK and raises money to fund projects for those affected by genetic conditions

Products and services

  • Support Services
  • Information Resources
  • Research Portfolio
  • Medical Professional Resources
  • Family Support Fund
  • Jeans for Genes Campaign
  • Membership Program
  • Pre-payment Prescription Service

Quantifiable outcome

  • 17 pre-payment prescriptions provided to families in 2024-2025
  • +3 more outcomes

Companies that use CGD Society

Customer profile

Named customers3 records

Segments3 records

Ideal customer profiles3 records

CGD Society technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration9 records

CGD Society partnerships and signals

Strategic signal

Partnerships

Five partnerships are on record, tiered core and minor.

  • EnsomacoreStrategic or Co-development PartnerCGD Society partnered with Ensoma, a genomic medicines company, to support the development of gene therapy for X-linked chronic granulomatous disease (X-CGD). The charity organized a patient advisory panel of five individuals directly affected by CGD to provide balanced feedback on the ongoing clinical trial. This collaboration ensures patient voices are integrated into the clinical development process.
  • Prime MedicinecoreStrategic or Co-development PartnerPrime Medicine developed PM359 prime editing programme for p47phox CGD. CGD Society maintained engagement with the company and shared community letters regarding their decision to deprioritize the CGD programme. The charity continues to monitor developments and explore partnership opportunities for PM359 continuation.
  • UCL Institute of Immunity and TransplantationcoreStrategic or Co-development PartnerCollaboration with UCL on research comparing allogeneic stem cell transplantation outcomes in adults with primary immunodeficiencies including CGD. The study found that transplant outcomes were better when performed at expert centres like UCLH or Newcastle.
  • Great Ormond Street Hospital (GOSH)coreStrategic or Co-development PartnerGOSH conducted pioneering gene therapy treatment on Remi, the first person in the world with p47 CGD to receive this therapy. The CGD Society celebrates this breakthrough and works with GOSH to raise awareness of treatment advances.
  • Gene People Partnership NetworkminorStrategic or Co-development PartnerThe CGD Society is part of the Gene People Partnership Network, a coalition of genetic condition charities working together for greater impact.

Scale indicators5 records

Recent moves6 records

Expansion highlights6 records

CGD Society competitors and assessment

Company assessment

Broad incumbents

  • National Organization for Rare Disorders (NORD): US-based umbrella organization for rare diseases. Comparable in providing advocacy, research funding programs, and patient resource infrastructure across the rare disease space that includes CGD.
  • Genetic Alliance UK: UK national alliance of over 200 patient organizations supporting people with genetic conditions. Comparable as a broader policy/advocacy incumbent that operates across the same genetic-disease ecosystem.
  • Gene People: UK umbrella alliance of genetic condition charities of which CGD Society is a member. Broad incumbent that aggregates policy, awareness, and network services across many rare genetic conditions, including CGD.
  • Rare Disease UK: National alliance for the rare disease community in the UK. Comparable in advocacy mission and stakeholder convening role across rare conditions including CGD, though not condition-specific.

Regional players

  • British Society for Immunology: UK professional body for immunologists. Comparable as an ecosystem participant that engages medical professionals treating primary immunodeficiencies, though it serves clinicians rather than patients directly.

Direct peers

  • Metabolic Support UK (formerly CLIMB): UK charity supporting patients and families affected by inherited metabolic diseases. Closely comparable operating model: small team, helpline, family support, information resources, and research engagement for a rare genetic condition.
  • PID UK: UK-based primary immunodeficiency patient organization. Closest UK peer offering helpline, family support, and medical-professional resources across the same PID disease area that includes CGD.
  • Immune Deficiency Foundation: US-based patient organization for primary immunodeficiencies (PIDs), including CGD. Directly comparable mission: provides patient/family support, physician education, advocacy, and research funding for the same rare immunodeficiency community.
  • Jeffrey Modell Foundation: Global foundation dedicated to primary immunodeficiencies including CGD. Comparable as a charity funding research, physician education, and patient advocacy for the same disease class.

Emerging players

  • Contact: UK charity supporting families with disabled children, including those with rare genetic conditions. Comparable in providing family support, helpline, and information services to a partially overlapping beneficiary population.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

CGD Society social profiles

Digital presence

CGD Society compliance and trust

Trust signal

Compliance2 records

CGD Society financial estimates

Financial estimate

Revenue estimate

Valuation estimate

CGD Society leadership team

Management profile

Number of profiles

Profiles1 record

CGD Society funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

CGD Society M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about CGD Society

What does CGD Society do?

The CGD Society is a UK-registered charity providing support, information, and advocacy for individuals and families affected by Chronic Granulomatous Disorder (CGD), a rare primary immunodeficiency. Its offerings include a telephone and email helpline, UK-based clinical nurse specialist services, a Family Support Fund, mental health and bereavement support, educational resources, and funding for research and clinical trials.

Is CGD Society a public or private company?

CGD Society is a private company. It is classified as nonprofit foundation owned and is currently operating.

When was CGD Society founded?

CGD Society was founded in -1. It employs 1 to 10 people.

Where is CGD Society based?

CGD Society is headquartered in Epsom, United Kingdom, in the Europe region.

How does CGD Society make money?

Five revenue lines are on record. Donations and Regular Giving is the primary driver. The others are jeans for Genes Campaign, corporate Support, membership and merchandise Sales.

Who are CGD Society's main competitors?

Broad incumbents on record are National Organization for Rare Disorders (NORD), Genetic Alliance UK, Gene People and Rare Disease UK. British Society for Immunology is listed as a regional player. Direct peers are Metabolic Support UK (formerly CLIMB), PID UK, Immune Deficiency Foundation and Jeffrey Modell Foundation. Contact is listed as an emerging player.

Does CGD Society have an API?

No public API is recorded for CGD Society.

What industry is CGD Society in?

CGD Society's product category is Patient Advocacy / Rare Disease Charity. Its primary akta.pro industry code is BPAGACAM, Rare Disease & Special Needs Support Organizations, with a secondary code of EDAJAIAK, Family & Community Support Services (Case Management, Referrals). Its NAICS code is 624190 and its SIC code is 8300.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales